This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2024
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2024 | 990 | $5,488,901 | $10,744,443 | $7,083,484 | $16,440,883 | $12,918,544 |
| FY2023 | 990 | $10,395,528 | $12,500,342 | $8,400,965 | $24,388,123 | $18,179,207 |
| FY2022 | 990 | $19,804,413 | $6,229,069 | $2,998,145 | $23,579,083 | $20,284,021 |
| FY2021 | 990 | $8,784,431 | $2,833,605 | $1,524,720 | $7,606,274 | $6,707,315 |
| FY2020 | 990 | $1,362,913 | $872,066 | $0 | $880,045 | $756,489 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 88% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| THE REGENTS OF UNIVERSITY OF CALIFORNIA UC SAN DIEGOLA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $4,721,574 | 2024 |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| The Regents of University of CaliforniaLa Jolla, CA | Support Cancer Research | $3,340,462 | 2023 |
| UCSD FoundationLa Jolla, CA | Support Cancer Research | $1,347,134 | 2022 |
| UC San Diego FoundationLa Jolla, CA | Support Cancer Research | $838,596 | 2021 |
| La Jolla Institute for ImmunologyLa Jolla, CA | Support Cancer Research | $603,832 | 2023 |
| LA JOLLA INSTITUTE FOR IMMUNOLOGYLA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $532,374 | 2024 |
| La Jolla Institute for ImmunologyLa Jolla, CA | Support Cancer Research | $464,486 | 2022 |
| SANFORD BURNHAM PREBYSLA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $411,561 | 2024 |
| Sanford Burnham Presbys MedicalLa Jolla, CA | Support Cancer Research | $400,000 | 2022 |
| Salk Institute for Biological StudiesLa Jolla, CA | Support Cancer Research | $385,950 | 2022 |
| BEKEN BIO INCSAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 | 2024 |
| PALM THERAPEUTICS INCSAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 | 2024 |
| SEREN BIO CORPENCINITAS, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 | 2024 |
| RESOLUTE SCIENCE INCSAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $250,000 | 2024 |
| Rady's Childrens Hospital San DiegoSan Diego, CA | Support Cancer Research | $228,708 | 2021 |
| Salk Institute for Biological StudiesLa Jolla, CA | Support Cancer Research | $228,708 | 2021 |
| Sanford Burnham Presbys Medical Discovery InstituteLa Jolla, CA | Support Cancer Research | $228,708 | 2021 |
| Rady's Children Hospital San DiegoSan Diego, CA | Support Cancer Research | $225,575 | 2022 |
| Rady's Children Hospital San DiegoSan Diego, CA | Support Cancer Research | $225,575 | 2023 |
| Scripps ResearchLa Jolla, CA | Support Cancer Research | $225,000 | 2023 |
| THE SALK INSTITUTE FOR BIOLOGICAL STUDIESLA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $207,926 | 2024 |
| SCRIPPS RESEARCHLA JOLLA, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $188,618 | 2024 |
| Scripps ResarchLa Jolla, CA | Support Cancer Research | $175,000 | 2022 |
| RADY CHILDREN'S HOSPITALSAN DIEGO, CA | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | $21,431 | 2024 |
| Sanford Burnham Presbys Medical CenterLa Jolla, CA | Support Cancer Research | $10,000 | 2023 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202422489349302002
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202332229349300528
Form 990 · FY2021 · period ending Dec 31, 2021IRS bulk XML
Filing id 202202589349302195
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202131249349302368
Form 990 · FY2019 · period ending Dec 31, 2019
Filing id 202040779349300644
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201911309349300301
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201821279349301512
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201711589349300026
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.